Prevalence of dyslipidemia and its associated factors among Jordanian adults

Journal of Clinical Lipidology

Volumn 4, Issue 1, 2010, Pages 53-58

  Khader, Yousef S ^a   Batieha, Anwar ^a   El Khateeb, Mohammed ^b   Al Omari, Mousa ^a   Ajlouni, Kamel ^b  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b National Center for Diabetes Endocrinology and Genetics Jordan   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; JORDAN; LIPID BLOOD LEVEL; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; JORDAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTORS; SECONDARY PREVENTION; SEX FACTORS; TRIGLYCERIDES;

EID: 75749134913     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2009.12.004     Document Type: Article

References (31)

1. INCLEN Multicentre Collaborative Group. Risk factors for cardiovascular disease in the developing world: A multicentre collaborative study in the International Clinical Epidemiology network (INCLEN). J Clin Epidemiol 45 (1992) 841-847
2. World Health Organization. World Health Report 2003: Shaping the Future (2003), WHO, Geneva, Switzerland
3. Murrray C.J., and Lopez A.D. Mortality by cause for eight regions of the world; Global Burden of Disease Study. Lancet 349 (1997) 1269-1276
4. Groundy S.M., and Small L.D.L. Atherogenic dyslipidemia and the metabolic syndrome. Circulation 95 (1997) 1-4
5. Haffnar M. Diabetes, hyperlipidemia and coronary artery disease. Am J Cardiol 83 Suppl (1999) 17F-21F
6. Wietlisbach V., Paccaud F., Rickenbach M., et al. Trends in cardiovascular risk factors (1984-1993) in a Swiss region: results of three population surveys. Prev Med 26 (1997) 523-533
7. Yamada M., Wong L.F., Kodama K., et al. Longitudinal trends in total serum cholesterol levels in a Japanese cohort, 1958-1986. J Clin Epidemiol 50 (1997) 425-434
8. Hodge A.M., Dowse G.K., Toelupe P., et al. The association of modernisation with dyslipidemia and changes in lipid levels in the Polynesian population of Western Samoa. Int J Epidemiol 26 (1997) 297-306
9. World Health Organization. Quantifying Selected Major risks to health. The World Health Reports 2002-Reducing Risks, Promoting Health Life (2002), World Health Organization, Geneva 47-97
10. Costa J., Borges M., David C., et al. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomized controlled trials. BMJ 332 (2006) 1115-1124
11. Cannon C.P., Steinberg B.A., Murphy S.A., et al. Meta-analysis of Cardiovascular outcomes trials, comparing intensive versus moderate statin therapy. J Am Coll Cardiol 48 (2006) 438-445
12. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of Cholesterol Lowering with Simvastatin in 20,536 high risk individuals. A randomized placebo-controlled trial. Lancet 360 (2002) 7-20
13. Baigent C., Keech A., Kearney P.M., et al. Cholesterol Treatment Trialists (CTT) Collaborators. Efficacy and Safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomized trials of statins. Lancet 366 (2005) 1267-1278
14. Grundy S.M., Cleeman J.I., Merz C.N., et al. Coordinating committee of the National Cholesterol Education Program Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardial 44 (2004) 720-730
15. Ajlouni K., Khader Y.S., Batieha A., et al. An increase in prevalence of diabetes mellitus in Jordan over 10 years. J Diabetes Complications 22 (2008) 317-324
16. Khader Y., Bateiha A., El-Khateeb M., et al. High prevalence of the metabolic syndrome among Northern Jordanians. J Diabetes Complications 21 (2007) 214-219
17. Khader Y., Batieha A., Ajlouni H., et al. Obesity in Jordan: prevalence, associated factors, comorbidities, and change in prevalence over ten years. Metab Syndr Relat Disord 6 (2008) 113-120
18. World Health Organization. Physical Status: The Use and Interpretation of Anthropometry: Report of a WHO Expert Committee. Technical Report Series (1995), World Health Organization, Geneva
19. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) et al. Circulation. 2002;106:3143-3421.
20. Verschuren W.M., Jacobs D.R., Bioemberg B.P., et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures: twenty-five year follow-up of the Seven Countries Study. JAMA 274 (1995) 131-136
21. The Health Benefits of Smoking Cessation. A report of the Surgeon General (1990), US Dept of Health and Human Services, Rockville, MD DHHS publication (CDC) 90-8416
22. Stamler J., Vaccaro O., Neaton J.D., et al. Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor intervention trial. Diabetes Care 16 (1993) 434-444
23. MacMahon S., Peto R., Culter J., et al. Blood pressure, Stroke and Coronary heart disease, 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335 (1990) 765-774
24. Pearson T.A., Blair S.N., Daniels S.R., et al., for the American Heart Association Science Advisory and Coordinating Committee. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular disease. Circulation 106 (2002) 388-391
25. Erem C., Hacihasanoglu A., Deger O., et al. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon Lipid Study. Endocrine 34 (2008) 36-51
26. Zahid N., Claussen B., and Hussain A. High prevalence of obesity, dyslipidemia and metabolic syndrome in a rural area in Pakistan. Diabetes Metabol Syndr 2 (2008) 13-19
27. Nguyen N.T., Magno C.P., Lane K.T., et al. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg 207 (2008) 928-934
28. Must A., Spadano J., Coakley E.H., et al. The disease burden associated with overweight and obesity. JAMA 282 (1999) 1523-1529
29. Brown C.D., Higgins M., Donato K.A., et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 8 (2000) 605-619
30. de Souza L.J., Souto Filho J.T., de Souza T.F., et al. Prevalence of dyslipidemia and risk factors in Campos dos Goytacazes, in the Brazilian state of Rio de Janeiro. Arq Bras Cardiol 81 (2003) 249-264
31. al-Nuaim A.R., Mirdad S., al-Rubeaan K., et al. Population-based epidemiological study on characteristics of risk factors of hypercholesterolemia in Saudi Arabia. Int J Cardiol 31 62 (1997) 47-54